Sobre Haohong Pharmaceutical

Haohong (Qihe) Pharmaceutical Technology Co., Ltd. is located in the High-tech Zone of Qihe County, Shandong Province, adjacent to the Yellow River and within the Jinan Economic Circle, enjoying convenient transportation. The company specializes in the R&D and custom production of innovative active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It passed the ISO 9001:2015 quality management system certification in 2021, was recognized as a Technology-based Small and Medium-sized Enterprise in 2024, and awarded Innovative Small and Medium-sized Enterprise of Shandong Province in 2025.

Haohong has a high-level R&D team and a full range of analytical testing instruments and methods. At present, its production base in Liaocheng is equipped with 30 sets of 3,000–5,000L reactors, with an annual production capacity of 1,000 tons.

The company focuses on the development of active pharmaceutical ingredients and intermediates for anti-cancer, anti-hepatitis C and anti-diabetic therapies, with an emphasis on high-grade intermediates. Its main products include Bicalutamide, Enzalutamide, Apalutamide, Darolutamide, Abemaciclib, Venetoclax, Macitentan, Empagliflozin, Larotrectinib, Apixaban, Rivaroxaban, Ibrutinib, Ceritinib, Pomalidomide, Lenalidomide, Ivacaftor, Tofacitinib, Cabozantinib, Alectinib, etc.

Our products are exported to overseas markets including the United States, Europe, Japan, India, Bangladesh and other regions. The company currently has dozens of high-grade intermediates available for commercial production, and also provides customers with efficient custom synthesis services ranging from gram scale to hundreds of kilograms.

Adhering to the corporate philosophy of "Pragmatism, Innovation, Integrity", Haohong is committed to serving global customers with full dedication!
🎓
Equipe de classe mundial
Formados em universidades de topo mundiais
🔬
P&D avançado
Desenvolvido internamente
🤖
Foco em inovação
Múltiplas tecnologias inovadoras

Nossos produtos

Ver todos os produtos → →
Alectinib Intermédio

Alectinib Intermédio

Modelo: 3241020916
Parâmetros: 1288336594

Ácido 2-Fluoro-4-Nitrobenzóico de alta pureza para síntese da apalutamida

Ácido 2-Fluoro-4-Nitrobenzóico de alta pureza para síntese da apalutamida

Modelo: 2-Fluoro-4-nitrobenzoic acid N-Methyl-2-fluoro-4-nitrobenzamide N-Methyl-2-fluoro-4-aminobenzamideN-Methyl-2-fluoro-4-bromobenzamideMethyl 4-bromo-2-fluorobenzoate 5-Amino-3-(trifluoromethyl)pyridinecarbonitrile
Parâmetros: 1959464418

6-Bromo-4-fluoro-1-isopropil-2-metil-1H-benzo[d]imidazole CAS 1356339-85-6 para Abemaciclib R&D

6-Bromo-4-fluoro-1-isopropil-2-metil-1H-benzo[d]imidazole CAS 1356339-85-6 para Abemaciclib R&D

Modelo: 4-Bromo-2,6-difluoroaniline5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine2-Bromo-5-formylpyridine4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Parâmetros: 1609841522

CAS 13096-62-3 2,3,4,6-Tetra-O-Benzil-D-Glucono-1,5-Lactona

CAS 13096-62-3 2,3,4,6-Tetra-O-Benzil-D-Glucono-1,5-Lactona

Modelo: 2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE
Parâmetros: 162511561X

Galeria da empresa

Factory
Factory
Laboratory
Laboratory
Reactor
Reactor
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Company Introduction
Company Introduction
Company Introduction
Company Introduction

Certificações e prêmios

Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
ISO 9001:2015 Quality Management System Certificate
ISO 9001:2015 Quality Management System Certificate

Histórias de sucesso

Top-tier Pharmaceutical Group

Top-tier Pharmaceutical Group

1High reaction yield reduces the production cost of finished pharmaceuticals.
2Low levels of impurities, heavy metals and residual solvents minimize drug safety risks.
3Stable quality across batches improves the consistency of customers’ pharmaceutical production.
4Simplified downstream synthesis processes shorten drug development cycles.
5Accelerates the drug registration process.
Ultra‑high purity with strictly controlled impurities, heavy metals and residual solvents.
Consistent quality batch‑to‑batch, stable crystal form and particle size.
Strict compliance with ICH, GMP and international pharmaceutical standards.
Stable large‑scale production capacity and reliable supply chain.
Customizable R&D support for API synthesis and drug registration.

Localização: US,AE,AU,BD,CA,CN,DE,FR,KR,SA,GB,IN,SG,SE 📦 Quantity: 200

Vídeos da empresa e produtos

▶

Introdução da empresa e tour pela fábrica

⏱ Duration: 3:45 | 👁 Views: 15,230

▶

Demonstração do produto - Kestrel K-1

⏱ Duration: 5:12 | 👁 Views: 28,450

▶

Showcase de inovação tecnológica

⏱ Duration: 4:30 | 👁 Views: 12,890

▶

Depoimentos de clientes e histórias de sucesso

⏱ Duration: 6:20 | 👁 Views: 9,650

Pronto para transformar sua vida?

Entre em contato agora para descobrir como nossos produtos podem atender às suas necessidades.